Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 18 of 24 pages ‹ First < 16 17 18 19 20 > Last ›
HSL9396
Madani KA, Al ESHAIWY.
Pharmacy in Saudi Arabia
International Pharmacy Journal 1992 Jul-Aug; 6:189-190, 192-194
HSL9402
Scheman C.
Prescription drug marketing and promotion-FDA perspective
Pharmaceutical Engineering 1992 Jul-Aug; 12:40-42
HSL4492
Cowley G.
Not what the doctor ordered: a study criticizes drug ads in medical journals
Newsweek 1992 Jun 9; 54
HSL4444
Waller PC, Wood SM, Langman MJ, Breckenridge AM, Rawlins MD.
Review of company postmarketing surveillance studies.
BMJ 1992 Jun 6; 304:(6840):1470-2
HSL2058
Wilkes MS, Doblin BH, Shapiro MF.
Pharmaceutical advertisements in leading medical journals: experts' assessments.
Ann Intern Med 1992 Jun 1; 116:(11):912-9
HSL4340
Fletcher RH, Fletcher SW.
Pharmaceutical advertisements in medical journals.
Ann Intern Med 1992 Jun 1; 116:(11):951-2
HSL4363
Kessler DA.
Addressing the problem of misleading advertising.
Ann Intern Med 1992 Jun 1; 116:(11):950-1
HSL9426
Wilkes MS, Doblin BH, Shapiro MF.
Pharmaceutical advertisements in leading medical journals: experts' assessments.
Ann Intern Med 1992 Jun 1; 116:(11):912-9
HSL1862
Schwartz TB.
Drug company marketing in the groves of academe.
West J Med 1992 Jun; 156:(6):660-1
HSL4490
Re: the marketing of adrenochrome
1992 Jun
HSL4491
Jones DC.
Pricing and promotion come under scrutiny
Scrip Magazine 1992 Jun; (5):16-18
www.pjbpubs.co.uk/scrip/scrhome.html
HSL9405
Brunko P.
Regulation of medicinal products for human use in the European Community
Irish Pharmacy Journal 1992 Jun; 70:210-212
HSL9422
Wassersug JD.
Pharmaceutical companies should provide physicians with prices of medications
Consultant Pharmacist 1992 Jun; 7:603, 605
HSL9439
Banks D.
Requirements of advertising and promotional labeling
ASHP Annual Meeting 1992 Jun; 49:
HSL9440
Feather KR.
Regulatory responsibilities of prescription drug advertising
ASHP Annual Meeting 1992 Jun; 49:
HSL9441
Graham CF.
Future outlook and guidelines for the Division of Drug Marketing, Advertising, and Communications
ASHP Annual Meeting 1992 Jun; 49:
HSL9442
Kienle PC.
Antibiotic use in a community hospital: trends over 13 years
ASHP Annual Meeting 1992 Jun; 49:
HSL4376
McGregor A.
WHO: World Health Assembly.
Lancet 1992 May 23; 339:(8804):1287
HSL20550
GM-1 ganglioside for Parkinson's?
SCRIP 1992 May 13; 1717:28
HSL9435
Thompson GA.
Cute sayings, costly drugs.
JAMA 1992 May 6; 267:(17):2327
HSL4489
Todd JS, Johnson KH.
Annotated guidelines on gifts to physicians from industry: American Medical Association Council on Ethical and Judicial Affairs
Journal of the Oklahoma State Medical Association 1992 May 01; 85:(5):227-231
HSL1863
Lichstein PR, Turner RC, O'Brien K.
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors
Arch Intern Med. 1992 May; 152:(5):1009-13.
HSL4419
Sanders AB, Keim SM, Sklar D, Adams J.
Emergency physicians and the biomedical industry.
Ann Emerg Med 1992 May; 21:(5):556-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB0-4FR075T-34&_coverDate=05%2F31%2F1992&_alid=392503706&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6696&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=743e9e73c0a768a49ef6426f97047518
HSL4487
Re: the promotion of chloramphenicol/streptomycin and Benadryl Expectorant and Humagel
1992 May;
HSL4488
An international code of pharmaceutical marketing practice
Health Action International 1992 May
HSL9398
Navarro RP.
Preventing drug noncompliance: partnering to provide complete pharmaceutical care
Medical Interface 1992 May; 5:25-26
HSL9438
FDA issues import alert against unapproved mail-order drugs.
Am J Hosp Pharm. 1992 May; 49:(5):1024
HSL9406
Smith M.
Rx to OTC: boon or boondoggle?
Drug Topics 1992 Apr 6; 136:96-103
HSL9420
Conlan MF.
S2000 defeated, but Pryor to keep fighting price hikes
Drug Topics 1992 Apr 6; 136:69-70
HSL5288
Murphy E, Spiegal N, Kinmonth AL.
'Will you help me with my research?' Gaining access to primary care settings and subjects.
Br J Gen Pract 1992 Apr 01; 42:(357):162-5
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3494&uid=1586554&db=PubMed&url=http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=1586554
HSL1617
Kligman M, Culver CM.
An analysis of interpersonal manipulation.
J Med Philos 1992 Apr; 17:(2):173-97
HSL4367
Lal A, Sharma ML.
Drug advertisements in Indian medical journals.
Indian J Physiol Pharmacol 1992 Apr; 36:(2):139-40
HSL4484
Mansfield PR.
Drug companies responses to the WHO Ethical Criteria
MaLAM Newsletter 1992 Apr4-6
HSL4485
Mansfield PR.
The IFPMA rejects the WHO Ethical Criteria
MaLAM Newsletter 1992 Apr1-3
HSL4486
Schofield I.
Prescrire—challenging marketing and promotional practices in France
Scrip Magazine 1992 Apr; (3):8-9
www.pjbpubs.co.uk/scrip/scrhome.html www.pjbpubs.co.uk/scrip/scrhome.html
HSL9427
Kahan JS, Martin CJ.
Extra-label uses of approved drugs
Pharmaceutical Executive 1992 Apr; 12:74, 76, 78, 80, 82
HSL20303
Lal A, Sharma ML.
Drug advertisements in Indian medical journals.
Indian J Physiol Pharmacol 1992 Apr; 36:(2):139-40
http://www.ncbi.nlm.nih.gov/pubmed/1506082
HSL4483
O’reilly D.
Drug doctors under fire
The Bulletin 1992 Mar 2420-21
HSL4302
Adikwu MU.
Abuse of brand names in era of essential drugs.
Lancet 1992 Mar 7; 339:(8793):623-4
HSL19905
Offerhaus L
Russia: Emergency drugs aid goes awry
The Lancet 1992 Mar 7; 339:(8793):607
http://www.lancet.com/journals/lancet/article/PII0140-6736%2892%2990883-5/fulltext
HSL1603
Sigmon JL, Anastasio GD.
Drug sample closet.
J Fam Pract 1992 Mar; 34:(3):262-3
HSL4314
Blank IH.
Industry-funded dermatologic research within academia in the United States: fiscal and ethical considerations.
J Invest Dermatol 1992 Mar; 98:(3):265-8
HSL4470
Miracle drugs or media drugs?
Consumer Reports 1992 Mar142-146
HSL4471
Re: the promotion of pipenzolate/phenobarbital
1992 Mar
HSL4482
Quijano RF.
Prescribing habits and attitudes of medical practitioners in the Philippines
Drug Monitor 1992 Mar-Apr; 7:(2):15-27
HSL9399
Griffin JP, Teeling-smith G.
View of the pharmaceutical industry on cost-effective prescribing
International Pharmacy Journal 1992 Mar-Apr; 6:58-64
HSL9429
Rubinstein E.
Payers: new attention to the U.S. outpatient market
Pharmaceutical Executive 1992 Mar; 12:56, 58, 60
HSL4352
Harvey K.
Other experiences: Australia
1992 Feb 21-23
HSL4353
Harvey K.
Pharmaceutical marketing
1992 Feb 21-23
HSL15305
Denig P, Haaijer-Ruskamp FM.
Therapeutic decision making of physicians.
Pharm Weekbl Sci 1992 Feb 21; 14:(1):9-15
http://www.ncbi.nlm.nih.gov/pubmed/1553253
HSL2716
Kline S.
Prescription drug advertising: Communicating risk, benefit and cost of pharmaceuticals
Canadian Public Health Association 1992 Feb 2-4; 52-6
HSL4354
Ho M, Armstrong A.
Monitoring of drug advertising in Canada
1992 Feb 2-4
HSL4423
Shantz M.
Prescription drug advertising
1992 Feb 2-449
HSL4428
Squires BP.
Prescription drug advertising
1992 Feb 2-4
HSL4307
Arkinstall WW.
Physicians and pharmaceutical companies.
CMAJ 1992 Feb 1; 146:(3):327-8
HSL4322
Canadian Medical Association.
Physicians and the pharmaceutical industry.
CMAJ 1992 Feb 1; 146:(3):388A-C
HSL4372
Macgregor AJ.
Physicians and pharmaceutical companies.
CMAJ 1992 Feb 1; 146:(3):327
HSL4469
Williams JR.
CMA guidelines on MD-drug industry relations part of international trend.
CMAJ 1992 Feb 1; 146:(3):386-8
HSL4458
Re: the promotion of multivitamins with zinc
1992 Feb
HSL4465
MaLAM Letter follow up—More about Wyeth Polymagma
MaLAM Newsletter 1992 Feb
HSL4466
Pushing drugs to doctors
Consumer Reports 1992 Feb87-94
HSL4467
Mutalik S.
Advertising, pharmaceutical industry, and dermatology.
Int J Dermatol 1992 Feb; 31:(2):144
HSL4468
Stang PE, Fox JL.
Adverse drug events and the Freedom of Information Act: an apple in Eden.
Ann Pharmacother 1992 Feb; 26:(2):238-43
HSL9431
Chi J.
Counterdetailing efforts reaching new heights
Drug Topics 1992 Feb; 136:1, 11
HSL9443
Hesterlee EJ.
Marketing communications: your prescription for better business
Iowa Pharm J 1992 Feb; 47:20-21
HSL9445
Bolger G, Goetsch R, Reinstein P.
Monitoring drug product quality.
Am Pharm 1992 Feb; NS32:(2):47-9
HSL4344
Gandy W.
Advertising baldly to the public.
N Engl J Med 1992 Jan 30; 326:(5):350-1
HSL4462
Broach M.
Direct-to-consumer advertising with added inducements [1st of 2 replies]
JAMA 1992 Jan 22-29; 267:(4):508
HSL4463
Kincaid MC.
Direct-to-consumer advertising with added inducements.
JAMA 1992 Jan 22-29; 267:(4):508
HSL4464
Morris LA, Graham CF.
Direct-to-consumer advertising with added inducements [2nd of 2 replies]
JAMA 1992 Jan 22-29; 267:(4):508
HSL4313
Blackwell RE.
Drug promotion and scientific exchange.
N Engl J Med 1992 Jan 9; 326:(2):133
HSL4318
Blue BA.
Drug promotion and scientific exchange.
N Engl J Med 1992 Jan 9; 326:(2):133
HSL4406
Ozols RF.
Drug promotion and scientific exchange.
N Engl J Med 1992 Jan 9; 326:(2):134
HSL4440
Vogel RM.
Drug promotion and scientific exchange.
N Engl J Med 1992 Jan 9; 326:(2):134
HSL4451
Wilbur RS.
Drug promotion and scientific exchange.
N Engl J Med 1992 Jan 9; 326:(2):133-4
HSL20528
Badwe R, Baum M
London Perspective: British medicines wrapped in fog
The Lancet 1992 Jan 4; 339:47
HSL1864
Brotzman GL, Mark DH.
Policies regulating the activities of pharmaceutical representatives in residency programs.
J Fam Pract 1992 Jan; 34:(1):54-7
HSL1865
Bucci KK, Frey KA.
Involvement of pharmacy faculty in the development of policies for pharmaceutical sales representatives.
J Fam Pract 1992 Jan; 34:(1):49-52
HSL2313
Cleary JD.
Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
J Pharm Technol 1992 Jan-Feb; 8:(1):27-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10118197&query_hl=21
HSL4383
Morelli D, Koenigsberg MR.
Sample medication dispensing in a residency practice.
J Fam Pract 1992 Jan; 34:(1):42-8
HSL4405
Ostergaard DJ.
Relationships between family physicians and the pharmaceutical industry.
J Fam Pract 1992 Jan; 34:(1):29-31
HSL4460
Prescription drug advertising in Canada: an assessment
1992 Jan
HSL4461
Step EL.
Editorial
Health Horizons 1992 Jan; (15):2
HSL9428
Kier KL, Kucukarslan SN.
Direct-to-consumer advertising of prescription drugs: implications to pharmacy practice
Ohio Pharmacist 1992 Jan; 41:21, 24
HSL9448
Spaulding CD, Josephs JW.
Is Rx couponing a viable direct-marketing technique?
Am Pharm 1992 Jan; NS32:(1):67-71
HSL9430
Cleary JD.
Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
J Pharm Technol 1992 Jan-Feb; 8:(1):27-9
HSL2043
Ayres I, Braithwaite J.
Responsive regulation: Transcending the deregulation debate.
Oxford: Oxford University Press 1992
http://www.oup.co.uk/isbn/0-19-509376-3
HSL4298
The IFPMA code of marketing practices: the first ten years 1981-1991
1992
HSL4300
No free lunches here
Lancet 1992; 340:365
HSL4301
Adams DG.
Pharmaceutical advertising: Education versus promotion
Journal of Pharmaceutical Marketing & Management 1992; 7:(1):53-66
HSL4304
Almarsdottir AB, Bush PJ.
The influence of drug advertising on children’s drug use attitudes and behaviors
Journal of Drug Issues 1992; 22:361-376
HSL4305
Anacker A.
Pharmaceutical promotion
New England Journal of Medicine 1992; 327:1686
HSL4308
Balasubramaniam K.
Children & rational use of drugs (the ARDA programme on chldren’s medicines)
1992
HSL4309
Bartone N.
The role of marketing research during drug development
Journal of Drug Issues 1992; 22:295-303
HSL4310
Basara LR.
Direct-to-consumer advertising: today’s issues and tomorrow’s outlook
Journal of Drug Issues 1992; 22:317-330
HSL4311
Bateman CR.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992; 146:328
HSL4315
Blank IH.
Reply
Journal of Investigative Dermatology 1992; 99:664-665
HSL4316
Bleidt B.
Marketing activities: the keystone of capitalism—increasing the availability of prescription drugs through pharmaceutical promotion
Journal of Drug Issues 1992; 22:277-293
HSL4317
Bleidt B.
Recent issues and concerns about pharmaceutical industry promotional efforts
Journal of Drug Issues 1992; 22:407-415
HSL4319
Blumenthal D.
Academic-industry relationships in the life sciences: Extent, consequences, and management.
JAMA 1992; 268:3344-3349
Page 18 of 24 pages ‹ First < 16 17 18 19 20 > Last ›
